AXA Framlington Health Z Inc (FUND:BRJZVQ7) - Fund price


Fund Report

AXA Framlington Health Fund Z INC

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)39.43 GBP
(18/10/2019)
Fund Size (mil)487.59 GBP
(30/09/2019)
Mkt Cap % 30/09/2019
FundCatBmark
Giant34.7548.6156.46
Large33.4524.0233.44
Medium18.2717.169.98
Small11.008.720.12
Micro2.531.490.00
Valuations and Growth Rates 30/09/2019
FundCategoryBenchmark
Price / Earnings17.6319.5916.51
Price/Book2.903.923.54
Price/Sales2.312.551.96
Price/Cash Flow9.3214.0313.31
Dividend-Yield Factor1.281.632.05
Long-Term Projected Earnings Growth11.349.859.50
Historical Earnings Growth17.3419.0114.86
Sales Growth6.637.036.68
Cash-Flow Growth4.835.514.25
Book-Value Growth5.545.654.10

Asset Allocation % 30/09/2019

Asset Allocation
LongShortNetCatBmark
Stocks99.620.0099.6298.23100.00
Bonds0.000.000.000.000.00
Cash0.540.170.381.670.00
Other0.000.000.000.100.00
World Regions % 30/09/2019
FundCategoryBenchmark
Greater Europe20.1124.0923.03
United Kingdom9.355.295.05
Eurozone7.316.846.26
Europe - ex Euro3.4511.9011.56
Europe - Emerging0.000.010.00
Africa0.000.000.00
Middle East0.000.040.15
Americas75.0569.7168.76
United States75.0569.3168.44
Canada0.000.250.32
Latin America0.000.150.00
Greater Asia4.846.208.22
Japan4.843.436.09
Australasia0.000.522.04
Asia - Developed0.000.520.00
Asia - Emerging0.001.730.09
Stock Sector Weightings % 30/09/2019
FundCategoryBenchmark
Cyclical0.000.510.00
Basic Materials-0.26-
Consumer Cyclical-0.18-
Financial Services-0.07-
Real Estate---
Sensitive5.072.141.02
Communication Services---
Energy---
Industrials-0.27-
Technology5.071.871.02
Defensive94.9397.3598.98
Consumer Defensive-0.39-
Healthcare94.9396.9598.98
Utilities---

Top 10 Holdings30/09/2019

Assets in Top 10 Holdings %41.06
Total Number of Equity Holdings57
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
Merck & Co Inc HealthcareUnited States7.06
DecreaseMedtronic PLC HealthcareUnited States4.90
GlaxoSmithKline PLC HealthcareUnited Kingdom4.83
Thermo Fisher Scientific Inc HealthcareUnited States4.73
Allergan PLC HealthcareUnited States3.81
Anthem Inc HealthcareUnited States3.53
UnitedHealth Group Inc HealthcareUnited States3.32
Takeda Pharmaceutical Co Ltd HealthcareJapan3.02
Becton, Dickinson and Co HealthcareUnited States3.02
AstraZeneca PLC HealthcareUnited Kingdom2.85
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.